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1521-6934/© 2014 Elsevier Ltd. All rights reservedPregnancy after solid organ transplantation is perfectly possible,
but it is associated with an increased risk of major obstetrical
complications including pre-eclampsia, foetal growth restriction
and preterm birth.
Following liver and kidney grafting, the risk of complications is
higher especially after kidney transplant, reﬂecting pre-existing
hypertensive and vascular disease. In these patients, prevention
should start before the onset of pregnancy through normalisation
of hypertensive and vascular conditions.
Following heart and lung transplants, the risk of rejection during
and after pregnancy remains signiﬁcant and an adequate immu-
nosuppression is imperative, especially after lung transplants
because of their intrinsic high rate of rejection.
A likely explanation for the higher risk of pregnancy complication
is an alteration of the ‘placental bed’, the decidua and the inner
myometrium underlying the placenta, a zone encompassing the
full length of the spiral arteries supplying maternal blood to the
placenta. Unfortunately, this zone has not been investigated in
pregnancy after solid organ transplantation.
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The ﬁrst woman to receive a kidney from her identical twin sister conceived within 2 years of the
transplantation and delivered twice, by caesarean section, two healthy babies after carrying both
pregnancies to term [1]. However, it is noteworthy that since the donor was an identical twin, immune
suppression was not an issue and pregnancy was facilitated. Pregnancy is integral to expectations of
women following vital organ transplantation. Unfortunately, despite thousands of successful preg-
nancies in solid organ transplant recipients, information regarding the outcome of these pregnancies
remains limited [2]. The available data to evaluate the risk of the major obstetrical syndromes after
solid organ transplantation come from transplantation pregnancy registers, including the National
Transplantation Pregnancy Registry (NTPR) [3], the United Kingdom Transplant Pregnancy Registry [4],
the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and the Australian National
Perinatal Epidemiology and Statistics Unit (NPESU) [5,6]. While today more data are available, studies
on the pathophysiology of pregnancies in transplanted women are still lacking.
Major obstetrical syndromes include pre-eclampsia or pregnancy-induced hypertension, preterm
birth and foetal growth restriction. In this contribution, we examine the incidence of major obstetrical
syndromes following different solid organ transplantation, including kidney, liver, heart and lung. The
critical uterine functions affected by solid organ transplantation and the risks associated with uterus
transplantation are discussed. Improved understanding of the pathogenesis of the major obstetrical
complications and early diagnosis will hopefully improve the outcome.
Major obstetrical syndromes in pregnant solid organ recipients
Successful pregnancy is possible after solid organ transplantation, but the risk of major obstetrical
disorders, including pre-eclampsia, preterm birth and foetal growth restriction, is high.
Kidney and liver transplants
Systematic reviews and meta-analyses of articles have recently evaluated pregnancy outcomes in
recipients of kidney and liver transplants. The Kidney Transfer Review reported on 4706 pregnancies in
3570 recipients [7]; the Liver Transfer Review included 450 pregnancies in 306 recipients [8]. The
comparison of pregnancy outcomes after kidney and liver transplantation in the United States shows a
signiﬁcant increase in the risk of major obstetrical complications, including pre-eclampsia, preterm
delivery and low birth weight (Table 1).
A recent population study, based on data from the ANZDATA and the NPESU, reported on 695
pregnancies in 447 kidney transplant recipients [9]. Themean gestational age at birthwas 35± 5weeks
in transplant recipients, signiﬁcantly shorter than the national average of 39 weeks (P < 0.0001). The
mean live birth weight for transplant recipients was lower than the national average (2485 ± 783 vs.
3358 ± 2g), a difference that remained signiﬁcant after controlling for gestational age. The authors
concluded that, although transplant pregnancies are generally successful, outcomes differ from the
general population in terms of perinatal survival rate, indicating that these pregnancies remain high
risk in spite of good allograft organ function.
Heart and lung transplantation
The ﬁrst successful pregnancy after heart transplantation was reported in 1988 [10]. The Heart
Transfer Review by Cowan et al. [11] included 103 pregnancies in 58 recipients whereas the Lung
Transfer Review by Shaner et al. [12] analysed 30 pregnancies with 32 outcomes (one triplet) in 21
female lung transplant recipients. Ten of the 21 recipients received a transplant because of cystic
ﬁbrosis and accounted for 12 pregnancy outcomes (seven live births, three spontaneous and two
therapeutic abortions).
The risk of pre-eclampsia increases after cardiac transplantation. In the NTPR, the incidence of pre-
eclampsia for cardiac recipients was 18% (Table 2), lower than that seen in kidney transplant recipients,
but higher than the 2e7% in healthy nulliparous women [13]. Wu et al. [14] reviewed the outcome of
Table 1
Risk of obstetrical syndromes after kidney and liver transplantation in the US.
Kidneya (n ¼ 4706) Liverb (n ¼ 450) Frequency in US population
Pre-eclampsia 27% 21.9% 3%
Preterm birth (<37 weeks) 45.6% 39.4% 12.5%
Birth weight (mean) 2420 g 2866 g (p < 0.001)
a Deshpande et al., 2011 [6].
b Deshpande et al., 2012 [7].
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after pregnancy remains signiﬁcant, rendering it necessary to maintain an adequate immunosup-
pression. This is especially true for lung transplants, which have a high rate of rejection independently
of pregnancy status. As emphasised by the authors, with a 5-year mortality rate of 50%, it is paramount
to counsel lung transplant patients regarding the impact of pregnancy on survival and their ability to
participate in raising the child.Co-morbidities
A number of associated factors, such as age, parity, chronic hypertension or renal disease, determine
the risk of pregnancy complications, including miscarriage and gestational diabetes, in the solid organ
recipient evenmore than the type of transplant. Chronic hypertension is a strongly unfavourable factor
in all four groups of transplantation (Table 3), and associated with early-onset pre-eclampsia, foetal
growth retardation and foetal death [13]. The high frequency of chronic hypertension in kidney re-
cipients may explain the excess of severe obstetrical disorders in this population. In a retrospective
study, Wielgos et al. [15] compared maternal, neonatal and graft outcomes in pregnant women after
kidney or liver transplantation. Complete data sets were collected in 38 pregnancies in 37 women. Pre-
existing hypertensionwas present in 15 of 19 (79%) pregnant kidney recipients and in two of 19 (10.5%)
pregnant women after liver transplantation (P < 0.000X). The incidence of pre-eclampsia was also
more prevalent in pregnant kidney recipients (P 0.04). The mean gestational age at labour was lower in
the kidney group (34.9 ± 3.56 vs. 37.5 ± 1.62, respectively; P < 0.000X). A similar relationship was
observed with the incidence of preterm deliveries before 37 weeks of gestation (42% vs. 11%, respec-
tively; P < 0.02) and small for gestational age (47% vs. 11%, respectively; P ¼ 0.008). It can be concluded
that pregnancies after solid organ transplantation, particularly those following kidney transplantation,
carry a high risk of major obstetrical syndromes, which in many cases reﬂect the impact of the un-
derlying hypertensive condition on the vascular remodelling associated with deep placentation [16].
Defective deep placentation in solid organ recipient pregnancies
Since its ﬁrst description in 1958 by Dixon and Robertson [17], the placental bed has come to be
recognised as a critical interface of pregnancy. The term ‘placental bed’ was coined to indicate that not
the basal plate of the placenta but the underlying decidua and the inner myometrium (the so-called
myometrial junction zone, or JZ) constitute the maternal part of the placenta (Fig. 1). This zone en-
compasses the full length of the spiral arteries supplying the maternal blood to the placenta. Instead ofTable 2
Risk of obstetrical syndromes after heart and lung transplantation, in the US.
Hearta (n ¼ 103) Lungb (n ¼ 30)
Pre-eclampsia 18% 3%
Preterm (<37 weeks) 38% 37%
Birth weight (mean) 2600 g 2206 g
Low birth weight (<2500 g) 39%
a Cowan et al., 2012 (NTPR) [11].
b Shaner et al., 2012 (NTPR) [12].
Table 3
Co-morbid conditions before or during pregnancy.
Kidneya (n ¼ 4706) Liverb (n ¼ 450) Lungc (n ¼ 30) Heartd (n ¼ 103)
Age (mean) 29.0 years 28.6 years NA NA
Miscarriage 14.0% 15.6% 30.0% 32.0%
Hypertension 54.2% 27.2% 53.0% 39.0%
Gestational diabetes 8.0% 5.1% 23.0% 2.0%
NA: not available.
a Deshpande et al., 2011 [6].
b Deshpande et al., 2012 [7].
c Cowan et al., 2012 (NTPR) [11].
d Shaner et al., 2012 (NTPR) [12].
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and maternal cells, changes in the placental bed are the key to ensuring adequate maternal blood
supply to the intervillous space of the placenta [18]. In pre-eclampsia, most spiral arteries, with the
exception of few in the centre of the placental bed, fail to undergo physiological changes in their
myometrial segments. In the case of pre-existing hypertension, these arteries develop, in a short space
of time, severe hyperplastic changes with superimposed acute atherosis [19]. The analysis of placental
bed biopsies and caesarean hysterectomy specimens conﬁrmed that the inadequate development of
the utero-placental vessels also causes foetal growth retardation [20]. Subsequent studies also reported
an association between impaired spiral artery remodelling and placental abruption [21], preterm
rupture of membranes [22] and preterm labour with intact membranes leading to preterm delivery
[23]. Therefore, defective deep placentation is not a speciﬁc lesion, but different types of vascular
changes underlie different major obstetrical disorders [16,24,25].
The placental vascular bed is more prone to developing obstructive atherosclerotic lesions in the
presence of subclinical hypertensive disorders when compared to other vascular beds. For this reason,
in kidney transplantation recipients, the increased risk of placental disease in the event of a pregnancy
is present many years prior to transplantation. In these women, alterations in the endothelial cell
morphology of glomerular capillaries, termed glomerular endotheliosis, also occur in unmodiﬁed spiral
arteries and is characterised by endothelial cell swelling and lipid accumulation [26,27]. Fibrin
deposition in the microvasculature is common. Affected women have an increased ratio of throm-
boxane A2 relative to prostacyclin (PGI2) in their urine and elevated plasma levels of endothelin
[28,29]. Importantly, elevated factor VIII consumption and increased levels of cellular ﬁbronectin
precede the onset of clinical manifestations in pregnancy [30,31]. Deep haemochorial placentation in
the human requires decidualisation of the endometrium and extends to the inner myometrial spiral
arteries in association with the invasion of the interstitial and later intravascular cytotrophoblast.
Impaired decidualisation of the myometrial spiral arteries predisposes for failed intravascular
trophoblast invasion. Because the decidual process in the human is controlled by crosstalk between sex
steroid hormones and locally released cytokines during the luteal phase of the cycle, the failure of
subsequent deep placentation may already have been determined in the conception cycle [32].
Unfortunately, no systematic research of the endometrium and the placental bed has been per-
formed to explain the high risk of obstetrical complications after solid organ transplantation.
Critical uterine functions
Decidualisation and embryo selection
Compared tomost mammals, two unique but poorly understood features characterise reproduction
in human: the high incidence of embryonic aneuploidies and ‘spontaneous’ decidualisation of the
endometrium, meaning that this process is driven by endocrine cues independently from the presence
or absence of an implanting blastocyst. A growing body of evidence indicates that the shift from
embryonic to maternal control of the decidual process represents a pivotal evolutionary adaptation to
the challenge posed by highly invasive and chromosomally diverse human embryos. This concept is
Fig. 1. Placental bed spiral arteries in normal pregnancy (A and B) and pregnancy with pre-eclampsia (C) and severe pre-eclampsia
(D). A, Full transformation characterised by the loss of musculo-elastic structure and the presence of ﬁbrinoid with cytotrophoblast;
B, partial transformation; periodic acideSchiff staining highlights the ﬁbrinoid in A and B. C, Absent transformation (note
trophoblastic giant cells surrounding the normal artery); D, obstructive lesions by acute atherosis and intimal hyperplasia and
absence of transformation. Reproduced, with permission, from Brosens [16].
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either promotes implantation and further development or facilitates early rejection [33]. Furthermore,
compelling evidence has emerged indicating that impaired decidualisation and lack of embryo se-
lection are themajor cause of early pregnancy loss and recurrentmiscarriage [34e36]. Because of cyclic
shedding and regeneration of the endometrium, the decidual process is intrinsically adaptable and
capable of changing, perhaps accounting for the fact that most women suffering miscarriages will
eventually be successful even without medical intervention [37].
At present, there have been no studies on the quality of the decidual response in non-pregnant
recipients. These studies are needed as they may provide insight into the likelihood of miscarriage
and the value of the luteal-phase progesterone support.
Vascular remodelling
Burton and Jauniaux [38] provided compelling evidence that early and late foetal development oc-
curs in very different environments. During the ﬁrst trimester, trophoblast plugging of the terminal
spiral arteries ensures that there is little or no maternal blood ﬂow to the early placenta. As a conse-
quence, the oxygen tensionwithin the foeto-placental unit is lowand nutritive support for the conceptus
is entirely dependent on secretions from the uterine glands and decidua. At the start of the second
trimester, the maternal circulation within the intervillous space becomes fully established, oxygen
tension rises and haemotrophic nutrition becomes dominant. During the transition part, there is a
period of placental oxidative stress and the response of the tissues to the changing oxygen concentration
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demonstrated that maternal variables together with the uterine artery pulsatility index at between 11
and 13 completed weeks of gestation provide sensitive prediction of the development of pre-eclampsia,
especially of the severe early-onset form. The net result of the intense tissue remodelling in the placental
bed is the conversion of some 100 arteries into distended, funnel-shaped, tortuous vessels, the true
utero-placental arteries. These vessels are devoid of musculo-elastic tissue and hence insensitive to
vasomotor cues. The sole purpose of the transformation of these arteries is to accommodate the dra-
matic increase of maternal blood ﬂow to the intervillous space as the pregnancy unfolds. Measurements
in the third trimester showed that a perfusion rate of the uterus and placenta is approximately 750 and
600 ml per minute, respectively [40]. This perfusion rate represents approximately 25% of the cardiac
output and a 17-fold increase from the rate of perfusion of a non-pregnant uterus [41].
Challenges to uterine functions in pregnancy after human uterus transplantation
In discussing uterus transplantation, it is of fundamental importance to realise that whereas the
procedure is technically feasible [42] and pregnancy can be achieved [43], proof that in the human a
transplanted uterus can sustain a normal pregnancy resulting in the birth of a healthy baby is still lacking.
In fact, this remains a highly contentious issue for a number of ethical and biological reasons. On the
biological side, three main issues exist: First, the uterus is not a ‘steady-state’ organ like kidney, liver
and most solid organs but requires great plasticity of the anastomosed vessels to accommodate the
increase of bloodstream during the second half of pregnancy. With respect to uterus transplantation,
the question arises how the extensive vascular adaptations associated with human deep placentation
are tolerated after uterine artery anastomosis surgery, which inevitably is associated with scar for-
mation particularly after a prolonged interval between surgery and pregnancy [44]. Second, while
animal experiments have shown that a successful pregnancy can be achieved after uterus trans-
plantation [45], these models are not representative for deep human placentation in which arterioles
with a diameter of 50 mmmust transform into large amorphic channels capable of accommodating 90%
of the uterine blood supply to the intervillous space. Third, it is important to realise that the uterus
cannot be viewed as an organ a priori designed to carry a pregnancy to term. For example, it is
increasingly apparent that cyclic waves of spontaneous decidualisation, menstruation and endometrial
regeneration play an important role in embryo selection at implantation and in the preconditioning of
the vasculature prior to deep trophoblast invasion [46].
Is immunosuppression interfering with deep placentation?
Spiral artery remodelling and deep placentation involve the inﬂux and presence of immune cells in
the utero-placental interface. Immunosuppressive therapy may affect the role of the immune cells,
such as the uterine natural killer cells and the T lymphocytes, in the decidua and the myometrial
junction zone.
Data from the literature, as well as from reports from the NTPR, support the concept that immu-
nosuppression be maintained at appropriate levels during pregnancy [47]. At present, most immu-
nosuppressive maintenance regimens include combination therapy, usually cyclosporine or tacrolimus
based. Most female transplant recipients will receive maintenance therapy prior to and during preg-
nancy. For some agents, including monoclonal antibodies and mycophenolate mofetil, there are either
concerns or lack of safety data in pregnancy [47].
The question arises whether immunosuppression in pregnancy may interfere with the immuno-
logical process of deep placentation in the human. Romero et al. [25] emphasised the importance of
understanding the physiology and pathology of transformation of the spiral arteries, and there are
ample experimental data showing that changes in the immune cell population or function at the
maternalefoetal interface contribute to the pathological pathways that cause obstetrical disorders. In a
nested caseecontrol study, Ogge et al. [48] (2011) investigated whether early-onset pre-eclampsia and
late-onset pre-eclampsia have different pathophysiologies. They determined the prevalence of
placental lesions attributable to persistent maternal under-perfusion in patients with pre-eclampsia as
a function of gestational age. The study showed that the earlier the gestational age at delivery, the
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onset pre-eclampsias seem to be a continuum with no clear and unambiguous gestational age at
which lesions consistent with under-perfusion would be present. This state of under-perfusion with
placental lesions has been linked to an imbalance in circulating concentrations of angiogenic versus
anti-angiogenic factors [49].
Management of major obstetrical syndromes in solid organ recipients
Multidisciplinary approach
The collaboration of the obstetrician, paediatrician and transplant physicians before, during and after
pregnancy and closemonitoring of the recipient aremandatory for better pregnancy and graft outcome.
The recommended time interval between transplantation surgery and conception should be at least 12
months and individualised according to the general health of the patient, maintenance presence of
stable immunosuppressive levels, stable graft function and fertility potential of the patient [3].
Preconception counselling
A consensus conference organised by the Women's Health Committee of the American Society of
Transplantation held in Bethesda, MD, in 2003 developed clinical guidelines for the transplant
physician and obstetrical health providers [50]. Many uncertainties still exist, including the risks that
pregnancy presents to the graft, the patient herself and the long-term risks to the foetus. The conse-
quences of decreased gestational age at delivery, particularly <34 weeks of gestation, include neonatal
death and long-term morbidities such as cerebral palsy, blindness, deafness and learning disabilities
and low intelligence quotients. In addition, low birth weight is associated with increased hypertension,
diabetes and coronary artery disease in adulthood [51]. These potential risks need to be discussed
frankly with the prospective parents and hard ethical discussions entertained.
First-trimester diagnosis of major obstetrical disorders
There has been a great interest in the screening during the ﬁrst trimester of women at risk of major
adverse pregnancy outcomes, utilising both risk assessments and biomarkers. Several promising
biomarkers have been proposed to identify women at the risk of subsequently developing pre-
eclampsia, foetal growth restriction and spontaneous preterm birth [52].
Pre-eclampsia
Recent studies have suggested that low serum concentrations of human chorionic gonadotrophin
(hCG) in very early pregnancy are associated with an increased risk of severe pre-eclampsia. Keikkala
et al. [53] demonstrated in a nested caseecontrol study that low concentrations of hyperglycosylated
human chorionic gonadotrophin (hCG-h) in the ﬁrst trimester are associated with subsequent pre-
eclampsia especially in mothers with early-onset disease. The predictive value can be further
improved by a combination of % hCG-h with pregnancy-associated plasma protein A (PAPP-A) and
maternal risk factors. They concluded that the combination of hCG-h with PAPP-A and maternal risk
factors identiﬁed such cases and that our ﬁndings are clinically relevant. It remains to be seenwhether
a combination of hCG-h with other markers and Doppler ultrasound measurements will further
improve the diagnostic accuracy.
In a prospective cohort study, Åsvold et al. [54] linked pregnancies after in vitro fertilisation (IVF) to
the Medical Birth Registry of Norway to obtain information on pre-eclampsia development. The study
included 2405 consecutive singleton pregnancies and examined the association of maternal serum hCG
concentrations on day 12 after embryo transfer with the risk of any pre-eclampsia and of mild and
severe pre-eclampsia. HCG concentrations were inversely associatedwith pre-eclampsia risk in a dose-
dependent manner (P trend 0.02). The inverse association was restricted to severe pre-eclampsia (P
trend 0.01); thus, womenwith hCG <50 IU/l were at a fourfold higher risk of severe pre-eclampsia than
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1.4e12.2). For mild pre-eclampsia, there was no corresponding association (P trend 0.36). These results
provide prospective evidence to support the hypothesis that impaired placental development may be
associated with subsequent development of severe pre-eclampsia. Karahasanovic et al. [55] found in a
smaller study that hCGb was signiﬁcantly lower in pregnancies that subsequently developed pre-
eclampsia, although in this study no signiﬁcant difference was found for PAPP-A.
The efﬁcacy of measuring hCG, alone or in combinationwith soluble fms-like tyrosine kinase 1 (sFlt-
1 or sVEGFR-1) and placental growth factor (PlGF), in predicting pre-eclampsia and preterm birth was
further investigated in a nested caseecontrol study [56]. This study found that high hCG concentrations
(highest quartile) in the ﬁrst trimester were associated with a reduced risk of preterm pre-eclampsia
(OR 0.3, 95% CI 0.1e0.9), comparedwith low hCG (lowest quartile), whereas high hCG concentrations in
the second trimester were associated with an increased risk of preterm pre-eclampsia (OR 4.0, 95% CI
1.8e8.9). High hCG concentrations in the third trimester were associated with an increased risk of term
pre-eclampsia (OR 4.8, 95% CI 1.8e13.3). Concentrations of hCG above themedian value combinedwith
PlGF below the median in the second trimester were associated with a very high risk of preterm pre-
eclampsia (OR 36.9, 95% CI 8.2e165.8). The results reﬂect an important role of hCG in the patho-
physiological processes that lead to pre-eclampsia. The combined association of hCG and PlGF indicates
a possible synergism between underlying biological pathways.
Foetal growth retardation
In a population-based prospective cohort study, Jaddoe et al. [57] showed that early foetal life might
be a critical period for cardiovascular health in later life. In 1184 children with ﬁrst-trimester foetal
crown to rump length measurements, whose mothers had a reliable ﬁrst day of their last menstrual
period and a regular menstrual cycle, the body mass index, total and abdominal fat distribution, blood
pressure and blood concentrations of cholesterol, triglycerides, insulin and C peptide at the median age
of 6.0 (90% range 5.7e6.8) years were measured. The childhood body mass index fully explained the
associations of ﬁrst-trimester foetal crown to rump length with childhood total fat mass. They
concluded that impaired ﬁrst-trimester foetal growth is associated with an adverse cardiovascular risk
proﬁle in school-age children.
Therefore, early foetal life might be a critical period for cardiovascular health in later life. Savasan
et al. [58] reviewed the second- and third-trimester serum and ultrasound markers predictive of
ischaemic placental disease including limited ﬁrst-trimester data. While current studies report a sta-
tistical association between marker levels and various adverse perinatal outcomes, the observed
diagnostic accuracy is below the threshold required for clinical utility. An exception to this general-
isation is uterine artery Doppler for the prediction of early-onset pre-eclampsia. Current guidelines
published by the Society for Maternal Fetal Medicine in the United States recommend the following:
(1) antepartum surveillance of a viable foetus with suspected intrauterine growth retardation includes
umbilical artery Doppler; (2) in pregnancies complicated by intrauterine growth retardation, antenatal
corticosteroids should be administered in the case of absent or reversed end-diastolic ﬂow in the
umbilical arteries <34 weeks; (3) pregnancies complicated by intrauterine growth retardation and
absent end-diastolic velocities in the umbilical artery may be managed expectantly until delivery at 34
weeks as long as foetal surveillance remains reassuring; and (4) pregnancies complicated by intra-
uterine growth retardation and reverse end-diastolic velocities in the umbilical arterymay bemanaged
expectantly until delivery at 32 weeks as long as foetal surveillance remains reassuring [59].
Spontaneous preterm birth
While the risk assessment for spontaneous preterm birth usingmaternal characteristics or previous
obstetric history alone is of poor predictive value [60,61], there are also no biochemical tests that have
been shown to be strongly predictive of subsequent spontaneous preterm birth. A transvaginal ul-
trasound of cervical length is the mainstay of mid-trimester screening of high-risk women but recent
data showed no correlation between ﬁrst-trimester short cervix alone and subsequent preterm birth
<34 weeks [62].
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Pregnancy following solid organ transplantation is becoming relatively common, particularly after
kidney and liver transplants. In all groups, however, major obstetrical syndromes are more frequent
than in the general population. Obstetrical syndromes, including pre-eclampsia, preterm birth and
foetal growth restriction, are higher for kidney than for liver or other solid organ transplantations. The
causes of the obstetrical complications after solid organ transplantation may be complex although
several important insights have emerged. First, solid organ transplantation increases the risk of
defective deep placentation in a subsequent pregnancy. Kidney transplant recipients have the highest
risk, presumably reﬂecting the presence of pre-existing hypertensive and vascular diseases. Second,
the uterine vascular bed e in contrast to other vascular beds e needs to provide in the event of a
pregnancy a unique vascular response with a great risk of developing obstructive, atherosclerotic le-
sions, even in the presence of subclinical hypertensive diseases. It has been shown that inwomenwith
renal disease a similar increased risk of complications already existed in pregnancies during the years
before the transplantation. Third, immunosuppression may perturb vascular remodelling in pregnancy
by affecting the key immune cells, such as uterine natural killer cells, present at the foeto-maternal
interface. Unfortunately, no attempts have been made to obtain placental bed biopsies and study the
vascular changes after organ transplantation. Meanwhile, the ﬁrst attempts to transplant the uterus in
order to obtain a pregnancy are performed. At present, the main advance for improving the outcome of
a pregnancy after solid organ transplantation is the early detection of any underlying maternal hy-
pertensive or vascular disorder. Meanwhile, themain target for improving the outcome of pregnancy in
women at risk is the strict antihypertensive treatment from the earliest stage of pregnancy. Multi-
disciplinary care from the earliest stage of the pregnancy is required as signs of foetal growth re-
striction can be detected from the early stage of pregnancy.Practice points
 Pregnancy after solid organ transplantation is associated with an increased risk of major
obstetrical complications including preeclampsia, fetal growth restriction and preterm birth.
 The higher risk after kidney transplantation reflects a pre-existing presence of hypertensive
and vascular disease.
 Prevention of major obstetrical syndromes should start before the onset of pregnancy by
normalizing the hypertensive and vascular condition.
Research agenda
 Biomarkers for the detection of defective placentation in early pregnancy
 Morphological and molecular study of the placental bed in solid-organ recipients
 Optimal management of hypertension and cardiovascular disease in pregnant solid organ
recipients
 Specific exploration of immunological issues relating to uterus transplantationDisclosure
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